Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 9/1/2001 First Published: 7/1/2001


1.		Phase II Study of ZD0473 in Patients With Progressive or Relapsed Non-Small Cell Lung Cancer Who Have Failed First-Line Platinum-Based Chemotherapy (Summary Last Modified 09/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				UCLA-000307201A ZENECA-0473IL/0003, NCI-G01-1974, NCT00021008


2.		Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				0402 IND No. 69,507, NCT00116610

Last Modified: 4/1/2002 First Published: 5/1/2001


3.		Phase I Study of ZD0473 and Doxorubicin HCl Liposome in Patients With Advanced Solid Tumors or Lymphoma (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				MSKCC-00044 NCI-G01-1942, NCT00016172

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute